Option Care Health/$OPCH
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Option Care Health
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others.
Ticker
$OPCH
Sector
Primary listing
Employees
7,052
Headquarters
Website
OPCH Metrics
BasicAdvanced
$4.3B
21.28
$1.27
0.81
-
Price and volume
Market cap
$4.3B
Beta
0.81
52-week high
$35.53
52-week low
$21.39
Average daily volume
2.2M
Financial strength
Current ratio
1.557
Quick ratio
0.952
Long term debt to equity
85.014
Total debt to equity
93.931
Interest coverage (TTM)
6.62%
Profitability
EBITDA (TTM)
401.285
Gross margin (TTM)
19.41%
Net profit margin (TTM)
3.78%
Operating margin (TTM)
6.03%
Effective tax rate (TTM)
25.92%
Revenue per employee (TTM)
$780,000
Management effectiveness
Return on assets (TTM)
6.03%
Return on equity (TTM)
15.02%
Valuation
Price to earnings (TTM)
21.285
Price to revenue (TTM)
0.805
Price to book
3.19
Price to tangible book (TTM)
-7.64
Price to free cash flow (TTM)
20.179
Free cash flow yield (TTM)
4.96%
Free cash flow per share (TTM)
1.34
Growth
Revenue change (TTM)
15.79%
Earnings per share change (TTM)
6.77%
3-year revenue growth (CAGR)
12.88%
3-year earnings per share growth (CAGR)
9.05%
What the Analysts think about OPCH
Analyst ratings (Buy, Hold, Sell) for Option Care Health stock.
Bulls say / Bears say
Option Care Health’s net revenue for Q3 2025 climbed 12.2% year-over-year to $1.435 billion, reflecting strong demand for its home and alternate-site infusion services (HME News).
Management raised full-year 2025 guidance, now forecasting net revenue of $5.60 billion–$5.65 billion and adjusted EBITDA of $468 million–$473 million, signaling confidence in continued growth (HME News).
Intramed Plus integration progressed well in Q1 2025, boosting Option Care’s presence in the southeastern U.S. and supporting broader use of an advanced practitioner model in infusion clinics (NASDAQ).
Cash provided by operating activities dropped 53.9% year-over-year to $90.3 million in Q2 2025, raising concerns about cash conversion and short-term liquidity (Globe Newswire).
GAAP gross profit margin shrank to 19.0% in Q2 2025 from 20.3% in Q2 2024, indicating margin pressure due to therapy-mix changes and STELARA economics (Nasdaq).
Roughly 58% of annual supply purchases are concentrated with a few key suppliers, and high payer concentration increases operational risk if contract disputes or supply interruptions arise (Nasdaq).
Data summarised monthly by Lightyear AI. Last updated on 3 Nov 2025.
OPCH Financial Performance
Revenues and expenses
OPCH Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Option Care Health stock?
Option Care Health (OPCH) has a market cap of $4.3B as of November 05, 2025.
What is the P/E ratio for Option Care Health stock?
The price to earnings (P/E) ratio for Option Care Health (OPCH) stock is 21.28 as of November 05, 2025.
Does Option Care Health stock pay dividends?
No, Option Care Health (OPCH) stock does not pay dividends to its shareholders as of November 05, 2025.
When is the next Option Care Health dividend payment date?
Option Care Health (OPCH) stock does not pay dividends to its shareholders.
What is the beta indicator for Option Care Health?
Option Care Health (OPCH) has a beta rating of 0.81. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.